Mepolizumab

Introduction

Mepolizumab is a monoclonal antibody medicine that targets and reduces eosinophils, a type of white blood cell involved in inflammation. It is primarily used in the treatment of severe eosinophilic asthma and other eosinophil-related disorders. Mepolizumab helps reduce the number of asthma flare-ups and improves breathing in patients who do not respond well to traditional therapies. It is administered under medical supervision and offers a targeted approach, making it a valuable option for long-term asthma management.

Uses of Mepolizumab

• Treatment of severe eosinophilic asthma
• Management of eosinophilic granulomatosis with polyangiitis (EGPA)
• Treatment of hypereosinophilic syndrome (HES)

How Mepolizumab works

Mepolizumab works by blocking interleukin-5 (IL-5), a protein responsible for the growth and activity of eosinophils. By targeting IL-5, it reduces eosinophil levels in the blood and tissues, helping to control inflammation and prevent asthma attacks or symptoms of other eosinophilic conditions.

Benefits of Mepolizumab

• Reduces frequency and severity of asthma attacks
• Improves lung function and breathing
• Decreases the need for oral corticosteroids
• Helps manage rare eosinophilic disorders effectively

How to take Mepolizumab

Mepolizumab is usually administered as a subcutaneous injection by a healthcare provider. It is typically given once every four weeks. Always follow your doctor's guidance and dosage schedule carefully. Do not self-administer unless instructed and trained to do so by a medical professional.

Type of Dosage Available

• Pre-filled syringe for subcutaneous injection
• Autoinjector pen (in select cases)

Side effects of Mepolizumab

• Headache
• Injection site reactions (redness, swelling)
• Back pain
• Fatigue
• Upper respiratory tract infections
• Allergic reactions (rare but serious)

Safety Advice

• Not recommended for acute asthma attacks
• Inform your doctor about any infections before use
• Use with caution in patients with parasitic infections
• Safe use in pregnancy or breastfeeding should be discussed with a doctor
• Regular monitoring of eosinophil levels may be required

Frequently Asked Questions (FAQs)

Q: What is Mepolizumab used for?
A: Mepolizumab is used to treat severe eosinophilic asthma, EGPA, and hypereosinophilic syndrome.

Q: Is Mepolizumab a steroid?
A: No, Mepolizumab is a monoclonal antibody, not a steroid. It targets specific immune cells involved in inflammation.

Q: How is Mepolizumab administered?
A: It is given as a subcutaneous injection, usually once every 4 weeks by a healthcare provider.

Q: Can Mepolizumab cure asthma?
A: Mepolizumab does not cure asthma but helps manage and control symptoms in patients with eosinophilic asthma.

Q: Are there any dietary restrictions while using Mepolizumab?
A: No specific dietary restrictions are associated with Mepolizumab, but always follow your doctor’s advice.